Webinars
Available On Demand
Experts from Trinity Life Sciences’ MedTech team partner with guest speaker, Mayuri Shah from Bain & Co., to deliver insights drawn from real case studies to inform how your organization can strengthen its commercial targeting and engagement strategies for ambulatory surgical centers (ASCs).
Register for this webinar to understand:
How ASC macrotrends are impacted by market events, procedure type, reimbursement and geography
How your organization can develop more informed commercial targeting and engagement strategies for ASCs to maximize product adoption, penetration and revenue
The implications…
Watch Now
Webinars
Available On Demand
Join Trinity Life Sciences’ Evidence, Value, Access and Pricing and Cell & Gene Therapy experts for a deeper look at the market access trends that will present the most impactful opportunities and challenges for life sciences organizations in 2023.This webinar will expand upon the trends discussed in the recently released white paper entitled “Global Market Access Trends: 2022 Edition,” focusing on evolving evidence expectations, increasing price transparency regulation and cell & gene therapy expansion.
Key Webinar Topics
How can life…
Watch Now
Webinars
Available On Demand
Is your company planning to begin commercial contracting or preparing to contract within a new channel?
If you are a leader in a pre-commercial or commercial emerging life sciences company facing these challenges, this webinar is designed for you.
Join our experts from TGaS Advisors, a division of Trinity Life Sciences, as we share what you need to know whether you are embarking on your commercial contracting journey or thinking about a new contracting channel such as payer contracting, provider…
Watch Now
Webinars
Available On Demand
Trinity invites life sciences executives to join us for a dynamic discussion on the most common high-impact challenges inherent in Business Development:
What contributes to inaccurate pricing and market access assumptions in the quick-paced Business Development process?
How do you de-risk pricing and access at each stage of the diligence process?
Chad Faulkner, Partner in Trinity’s Strategic Advisory practice, will host this session and moderate a panel with special guests Monica Martin De Bustamante—Senior Partner & Head of Evidence, Value,…
Watch Now
Webinars
Available On Demand
What are the latest incentive compensation trends that you need to know to remain competitive in the quest for talent?
TGaS Advisors, a division of Trinity Life Sciences, explored this question as part of our 12th Annual Incentive Compensation Landscape – the most comprehensive study of its kind in the life sciences industry. We surveyed Incentive Compensation (IC) leaders at 54 life sciences companies of all sizes to gain their perspectives on current trends and best practices in incentive compensation…
Watch Now
Webinars
Available On Demand
Secure success in bringing your novel therapies to market with Trinity’s innovative, holistic approach to valuing early-stage assets.
Biopharma companies have been experiencing record levels of growth in recent years through M&A, co-developments, joint ventures, licensing agreements and other partnership deals. It is unlikely that this accelerated growth would have been sustained using traditional methodologies that are less able to generate realistic valuations for complex innovative therapies. Using traditional valuation methods, we likely would not have seen the commercialization of…
Watch Now
Webinars
Available On Demand
Whether you are an emerging, mid-tier or large-tier company preparing for launch, now is the time to challenge conventional thinking.
We have all seen the dramatic shifts in scientific innovation in the life sciences industry that have been further accelerated by the COVID-19 pandemic. Despite these shifts, Trinity Life Sciences found that the commercial models employed by companies that launched new products recently were still largely based on traditional sales and marketing approaches.
In reaction to these findings, our experts…
Watch Now
Webinars
Available On Demand
What do ‘pricing inflation penalties’ actually mean for manufacturers of biopharma products?
Explore the impact of the Inflation Reduction Act (IRA) on biopharmaceutical product net prices and contract strategies as manufacturers adapt to new U.S. market conditions.
In this webinar, Trinity Life Sciences’ Evidence, Value, Access & Pricing practice experts will provide a high-level review of IRA policy updates before exploring the implications for currently marketed Medicare Part B and Part D therapies, as well as for future product launches.…
Watch Now
Webinars
Available On Demand
Demonstrating and communicating the value story to clinicians and payers is critical for successful commercialization, but there are many scenarios where new products may struggle to differentiate themselves. If you have a better mousetrap, how do you demonstrate value to support pricing, access, adoption and reimbursement?
The HEOR Evidence Strategy team at Trinity Life Sciences will conduct a webinar to explore this important question and share several case studies where we worked with companies facing this challenge. We will also…
Watch Now
Webinars
Available On Demand
What do pharmaceutical manufacturers need to know to successfully navigate the market access landscape in China through the latest NRDL update?
The access landscape in China is rapidly evolving with important implications for novel medicines. The most recent update of China’s National Reimbursement Drug List (NRDL) in 2021 focused on the expansion of new and high-cost innovative therapies and highlighted the improving access environment for these drugs.
In this webinar, Trinity Life Sciences’ Value, Access and Pricing experts will provide…
Watch Now
